Puissance Capital Management LP - BELLEROPHON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Puissance Capital Management LP ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$2,902,000
-27.5%
8,298,7550.0%7.20%
-19.3%
Q3 2019$4,001,000
-19.5%
8,298,7550.0%8.92%
+83.4%
Q2 2019$4,973,000
-8.2%
8,298,7550.0%4.87%
+10.4%
Q1 2019$5,419,000
-18.5%
8,298,7550.0%4.41%
-41.9%
Q4 2018$6,651,000
-25.8%
8,298,7550.0%7.59%
+21.3%
Q3 2018$8,963,000
-55.4%
8,298,7550.0%6.26%
-58.6%
Q2 2018$20,083,000
+16.3%
8,298,7550.0%15.10%
+1.5%
Q1 2018$17,261,000
-19.4%
8,298,7550.0%14.88%
+0.6%
Q4 2017$21,410,0008,298,75514.79%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KLINSKY STEVEN B 4,859,885$44,614,00020.33%
Senator Investment Group LP 448,679$4,119,0000.04%
HIGHLAND CAPITAL MANAGEMENT LP 162,177$1,489,0000.03%
Baker Brothers Advisors 350,000$3,213,0000.03%
Alyeska Investment Group, L.P. 94,131$864,0000.01%
SABBY MANAGEMENT, LLC 30,000$275,0000.01%
FMR LLC 1,302,070$11,953,0000.00%
MILLENNIUM MANAGEMENT LLC 15,427$142,0000.00%
BlackRock Investment Management, LLC 846$8,0000.00%
GOLDMAN SACHS GROUP INC 17,290$159,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders